Critical Care Air Transport Team (CCATT) Initial Practice Test

Patients receiving neuromuscular blocking agents are primarily at risk for respiratory compromise and may require mechanical ventilation. These agents work by inhibiting neuromuscular transmission at the neuromuscular junction, leading to muscle paralysis. While this paralysis can be useful during surgical procedures for facilitating intubation and improving surgical conditions, it poses significant risks if not monitored correctly.

One of the critical implications of this paralysis is the loss of spontaneous respiratory effort, meaning that if the respiratory muscles become incapacitated, the patient will not be able to maintain adequate ventilation on their own. Therefore, it is often necessary to provide mechanical ventilation to support breathing until the effects of the neuromuscular blocker wear off and the patient can regain normal respiratory function. The careful management of patients receiving these agents is essential to prevent respiratory failure and ensure patient safety during and after their procedures.